In Morocco, the current female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 is 22.3%, which reflects a decrease of 0.1% (-0.4%) compared to 2018.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in Morocco
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to Morocco
Female CVD, cancer, diabetes or CRD
More indicators for Morocco
Out-of-pocket expenditure PPP per capita
intl dollar231
+intl dollar25
(2021)
Newborns protected against tetanus
93%
+3%
(2022)
Female wasting in children
2.8%
+1%
(2017)
Birth registration
96.9%
+2.9%
(2018)
Female prevalence of HIV
0.1%
0%
(2022)
Contraceptive modern method prevalence
59.1%
+0.5%
(2018)
Morocco Female CVD, cancer, diabetes or CRD between 2000 and 2019
| Period | Female CVD, cancer, diabetes or CRD | Change |
|---|---|---|
| 2019 | 22.3% | -0.1% |
| 2018 | 22.4% | -0.2% |
| 2017 | 22.6% | -0.1% |
| 2016 | 22.7% | -0.2% |
| 2015 | 22.9% | -0.2% |
| 2014 | 23.1% | -0.3% |
| 2013 | 23.4% | -0.2% |
| 2012 | 23.6% | -0.2% |
| 2011 | 23.8% | -0.2% |
| 2010 | 24% | -0.2% |
| 2009 | 24.2% | -0.2% |
| 2008 | 24.4% | -0.1% |
| 2007 | 24.5% | +0.1% |
| 2006 | 24.4% | 0% |
| 2005 | 24.4% | +0.1% |
| 2004 | 24.3% | 0% |
| 2003 | 24.3% | 0% |
| 2002 | 24.3% | 0% |
| 2001 | 24.3% | -0.1% |
| 2000 | 24.4% |